Cronos Group Inc (CRON) Stock Analysis

Cronos Group Inc (CRON) is a publicly traded company in the HEALTHCARE sector. It trades at $2.73, carries a market capitalization of $1.05B. This page summarizes the public market data, fundamentals, and frequently asked questions for CRON, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - DRUG MANUFACTURERS - SPECIALTY & GENERIC

Exchange: NASDAQ

Key Metrics

Market Sentiment

Cronos Group Inc currently has a Bullish sentiment score of 0.29.

About Cronos Group Inc

Cronos Group Inc. is a prominent cannabinoid company headquartered in Toronto, Canada, that excels in the development and distribution of innovative cannabis products. Committed to pioneering advancements in cannabis science, the company emphasizes robust research and development to deliver unique offerings catering to both medical and recreational sectors. Through strategic partnerships and targeted investments, Cronos is poised to expand its global footprint, solidifying its role as a signi...

GNG Research Analysis

GNG Research scores Cronos Group Inc (CRON) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CRON.

Frequently Asked Questions

Does CRON pay dividends?

Cronos Group Inc (CRON) does not currently pay a regular dividend.

What is CRON's market cap?

Cronos Group Inc (CRON) has a market capitalization of $1.05B with a current stock price of $2.73.